Share page on Facebook Share page on Twitter Share page on LinkedIn We have mainly grown organically, but have bolstered our growth through a number of strategic acquisitions which have broadened our service portfolio and have added scale to existing services. 2021 ICON acquires PRA Health Sciences, creating the most advanced healthcare intelligence and clinical research organisation in the world 2020 ICON acquires MedPass International, a leading European medical device CRO, regulatory and reimbursement consultancy 2019 ICON acquires Symphony Clinical Research, a leading provider of at-home patient services and site support services ICON acquires MediNova, an integrated network of clinical research sites across EMEA ICON acquires MolecularMD to enhance laboratory offering in molecular diagnostic testing and immunohistochemistry 2017 ICON acquires MAPI Group to become world’s 2nd largest provider of late phase services 2016 ICON acquires Clinical Research Management Inc. to extend presence in the government sponsored research market ICON selected by Genomics England to support the world's largest genome sequencing project ICON selected by ICHOM to develop world’s first global healthcare outcomes benchmarking programme 2015 ICON celebrates 25 years ICON creates new global innovation hub in Ireland to advance clinical development ICON acquires MediMedia Pharma Solutions to enhance market access and scientific communications capabilities ICON acquires PMG Research Inc, an integrated network of clinical research sites in the US ICON launches Medical Device and Diagnostics Research Group 2014 ICON acquires Aptiv Solutions, a market leader in adaptive trial design and execution 2013 ICON acquires staffing and FSP providers, ClinForce and Assent ICON acquires Akos, an EU Provider of Pharmacovigilance and Drug Safety Services 2012 ICON acquires PriceSpective, a global value strategy consultancy ICON acquires Chinese CRO, BeijingWits 2011 ICON acquires Oxford Outcomes, an international health outcomes consultancy ICON acquires Firecrest Clinical, a technology provider specialising in site performance and study management 2010 ICON acquires Timaq Medical Imaging Inc. 2009 ICON acquires Veeda Laboratories, a UK Biomarker Lab 2008 ICON acquires US Phase I Provider Healthcare Discoveries ICON acquires US Bioanalytical Lab, Prevalere Life Sciences 2007 ICON acquires European staffing group, DOCS International 2006 ICON acquires Outcomes Research and Health Economics specialist, Ovation Research Group 2005 ICON opens first Indian office in Chennai 2004 ICON acquires medical imaging specialist, Beacon Bioscience Inc. 2003 ICON acquires Medeval, a UK-based Phase I facility ICON acquires US consulting firm, Globomax 2002 ICON acquires staffing group, Managed Clinical Solutions ICON opens first African office in South Africa ICON acquires clinical research provider, BPA 2000 ICON acquires UK-based regulatory consultancy, YRCR Ltd. ICON acquires Central Laboratory in New York ICON acquires bioanalytical consultancy, Pacific Research 1999 ICON opens its first Middle East office in Israel 1998 ICON begins trading on the Nasdaq exchange ICON opens its first South American office in Buenos Aires, Argentina 1997 ICON’s Hans Werner Voss conducts world’s first Adaptive Clinical Trial for an asthma study 1996 ICON opens its first Asian office in Tokyo, Japan 1995 ICON opens its first office in Germany 1992 ICON opens its first US office in Philadelphia 1991 ICON opens its first overseas office in Winchester, UK 1990 ICON founded in Dublin, Ireland, by Dr. John Climax & Dr. Ronan Lambe IN THIS SECTION Company history ICON in Asia Pacific ICON in Latin America Leadership Quality Environmental, Social & Governance ICON and You Connect with us Contact us Submit proposal request Update Email Preferences Global office locator ICON on social media Contact About ICON Results & Reports For Clients Therapeutics Services Insights Innovation Content Preferences Office locations ICON For Patients Volunteers Investigators Jobs & Careers Investors Suppliers News & Events Press Releases Mediakit Events Social Media Dashboard LinkedIn Twitter Facebook Youtube © 2021 ICON plc Disclaimer Privacy Site Cookies We use cookies on this website We use cookies to enhance your website experience. We use necessary cookies to ensure our website functions properly and to keep it secure. These always need to be on. By clicking “Accept all”, you agree to the storing of cookies on your device to enhance site navigation, analyse site usage, and assist in our marketing efforts. Please view our cookie policy for further details.. Accept all Manage cookies